6-26156445-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_005321.3(H1-4):c.55C>T(p.Pro19Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000179 in 1,610,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005321.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
H1-4 | NM_005321.3 | c.55C>T | p.Pro19Ser | missense_variant | 1/1 | ENST00000304218.6 | NP_005312.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
H1-4 | ENST00000304218.6 | c.55C>T | p.Pro19Ser | missense_variant | 1/1 | NM_005321.3 | ENSP00000307705 | P1 | ||
ENST00000707189.1 | n.999+32274C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152278Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000935 AC: 23AN: 245946Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134252
GnomAD4 exome AF: 0.000184 AC: 269AN: 1458472Hom.: 0 Cov.: 31 AF XY: 0.000200 AC XY: 145AN XY: 725360
GnomAD4 genome AF: 0.000131 AC: 20AN: 152396Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74530
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at